Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: May 10 2020

Lung Cancer

  • Snapshot
    • A 69-year-old male with a 50 pack-year smoking history presents to his physician with complaint of worsening cough. He describes frequently coughing up blood in the past few weeks. He has unintentionally lost about 10 pounds of weight in the past month and has felt more fatigued than usual. On physical examination, he has ptosis and a constricted pupil in his left eye. His right eye is normal. A chest radiograph is obtained and is shown in the image.
  • Introduction
    • Overview lung cancer is a malignancy that affects the lung parenchyma or airways
      • most lung cancers can be divided into
        • small cell lung cancer
        • non-small cell lung cancer
    • Epidemiology
      • incidence
        • second most common cancer
        • leading cause of cancer-related death
      • risk factors
        • cigarette smoking
          • most important risk factor
          • second-hand smoke exposure is also a risk factor
        • asbestos
        • radon
        • family history of lung cancer
    • Prognosis
      • depends on cancer type and severity
    • Screening
      • performed with a low-dose computerized tomography (CT) scan of the chest
        • indicated in patients 55-80 years of age who have a 30 pack-year smoking history and either of the following
          • currently smoke
          • has quit smoking within the past 15 years
  • Classification
      • Small Cell Lung Cancer (SCLC)
      • Type
      • Location
      • Associated Findings
      • Histology
      • Small cell (oat cell)lung cancer
      • Central
      • MYC gene amplication
      • May produce
        • adrenocorticotropic hormone (ACTH)
          • leads to Cushing syndrome
      • excessive anti-diuretic hormone (ADH)
        • leads to syndrome of inappropriate ADH (SIADH)
      • presynaptic calcium channel antibodies
        • leads to Lambert Eaton syndrome
      • Small dark blue tumor cells with lack of nucleoli and high nuclear:cytoplasm ratio
      • Positive staining for 
        • neuron-specific enolase
        • chromogranin A
      • Non-Small Cell Lung Cancer (NSCLC)
      • Type
      • Location
      • Associated Findings
      • Histology
      • Adenocarcinoma
      • Peripheral
      • Most common
        • cause of lung cancer in non-smokers
        • cause of lung cancer (excluding metastasis)
      • Adenocarcinoma in situ
        • tumor growth along alveolar structures
          • lepidic growth pattern
      • Patients may havehypertrophic osteoarthropathy
      • Common gene mutations include
        • KRAS
        • EGFR
        • ALK
      • Typically mucin positive and has a glandular appearance
      • Large cell carcinoma
      • Peripheral
      • Associated with a poor prognosis
      • Highly associated with smoking
      • Pleomorphic giant cells
      • Squamous cell carcinoma of the lung
      • Central
      • Can arise from the bronchus
      • Keratin pearls
      • Intracellular bridges
      • Bronchial carcinoid tumor
      • Central or peripheral
      • Carcinoid syndrome
      • Better prognosis
      • Neuroendocrine cells
      • Chromogranin A positive
  • Presentation
    • Symptoms
      • cough
      • wheezing
      • unintentional weight loss
      • hemoptysis
      • chest pain
      • dyspnea
      • hoarseness
        • suggests involvement of the recurrent laryngeal nerve
    • Physical exam
      • finger clubbing
  • Imaging
    • Radiography
      • indication
        • initial imaging modality when evaluating a patient with symptoms concerning for lung cancer
          • very important to review previous chest imaging to assess for lesion properties and changes
    • Computerized tomography (CT) scan
      • indication
        • perform with low-doses to screen for lung cancer (review "screening" in the introduction)
        • further evaluate pulmonary nodule found on radiography
          • chest CT should be obtained for all patients with an unclearly characterized solitary pulmonary nodule seen on radiography
  • Studies
    • Laboratory testing
      • complete blood count
      • liver function tests (e.g., alanine aminotransferase, aspartate aminotransferase, and total bilirubin)
        • abnormalities may suggest liver metastasis
      • alkaline phosphatase
        • abnormalities may suggest liver or bone metastasis
          • a gamma-glutamyl transpeptidase (GGT) should be obtained to differentiate between liver or bone involvement
      • calcium
        • abnormalities may suggest bone metastasis or paraneoplastic syndromes
    • Pulmonary function tests
    • Evaluation of an incidental solitary pulmonary nodule
      • introduction
        • benign features
          • diffuse
          • central
          • popcorn
          • concentric
        • malignant features
          • ground-glass
          • eccentric
      • solitary pulmonary nodule < 8mm
        • if there are or are not risk factors, one typically does surveillance with a chest CT in a few months depending on the size of the lesion
      • solitary pulmonary nodule > 8mm
        • very low probability of malignancy
          • CT surveillance
        • low/moderate probability of malignancy
          • positron emission tomography (PET) scan
            • if absent or mild uptake
              • CT surveillance
            • if moderate or intense uptake
              • biopsy or video-assisted thoracoscopic surgery
        • high probability of malignancy
          • staging evaluation with or without PET scan
  • Differential
    • Tuberculosis
      • differentiating factors
        • abnormal quantiferon or purified protein derivative (PPD) test
        • history of ↑ risk of exposure (e.g., household contact with someone with diagnosed tuberculosis or travel to tuberculosis-endemic area)
  • Treatment
    • Small cell lung cancer
      • most cases are non-resectable and thus require chemotherapy (e.g., carboplatin and etoposide)
    • Non-small cell lung cancer
      • treatment includes surgical removal, lymph node sampling or dissection, radiation, and chemotherapy
        • depends on the staging
  • Complications
    • Superior vena cava syndrome
    • Pancoast tumor
      • may cause Horner syndrome
    • Metastasis
    • Pericardial effusion
    • Pleural effusion
    • Paraneoplastic syndromes
      • hypercalcemia of malignancy
        • ectopic secretion of PTH-related protein (PTHrP)
      • Lambert-Eaton syndrome
      • SIADH
      • Cushing syndrome
1 of 0
1 of 13
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options